During its beginnings, Platech applied to 2 university competitions, "Aplica tu idea" and "JUMP Chile", from which it obtained its first money prizes to begin developing the idea. In both contests, Platech managed to strengthen its knowledge in the entrepreneurship area through the different workshops given, creating the commercial strategy, the business model, work plan and future flows to raise investment and carry out the first laboratory tests.
Thanks to these competitions, the Ministry of Foreign Affairs chose Platech as one of the 5 nascent companies with greatest future in biomedicine and gave them a place for a training carried out by the TEchFW incubator in Texas. This training allowed the validation of the idea not only at the national level, but also internationally.
Later, together with the mentoring sessions carried out by Universidad Andrés Bello (UNAB) and the expert in innovation management and technology transfer Miguel Rebolledo, Platech strengthens its strategy and business model, aiming at the validation of innovation worldwide. In 2015, the company applied to the global innovation competition GIST (Global Innovation through Science and Technology), winning the world award for scientific excellence, the most important competition award for the biotechnology sector.
In 2016, the company was awarded the CORFO seed capital subsidy, which allowed confirming the concept of the venture, validating its innovation on a laboratory scale. This validation and the correct execution of the seed capital, gave way to the first capital raising, obtaining strategic allies and financing for the construction of the current laboratory in the city of Viña del Mar. Along with this investment, they were awarded a new CORFO subsidy called Entrepreneurial Technological Innovation, allowing them to validate the bioprocess on a semi-industrial scale of 1 liter. In 2019, the company's R&D passes the current theoretical knowledge level worldwide and gives way to the development of a new and innovative bioprocess capable of cultivating super-producing cells of human platelet proteins in a bioreactor designed and standardized by Platech and their collaborators, the Catalan company TECNIC. This allowed Platech to be awarded the CORFO High Technology Innovation subsidy in 2020, which together with the investment plan will allow the completion of the development of the main project, N4Cells.